BirdoTech specializes in small-molecules process R&D, supplying pharmaceutical raw materials and active pharmaceutical intermediates (API)

Communications is the critical glue to the execution of a project. BirdoTech’s project management team is US-based and is staffed by experienced pharmaceutical chemists. This arrangement allows for more efficient communications with their US and European clients around the clock. Their project managers bring their experiences from the pharma industry. They understand the western culture, the expectations, and the complex regulations between different regions of the world. Oftentimes, stakeholders on all sides must juggle among shifting targets, compressing timelines, and staying within budgets. Regardless of the expectations, they work tirelessly to deliver. Their responsibilities encompass scientific, business, and logistics. Some recent challenges have included tariffs and reduced flight capacities during import/export.

Recognizing the importance of quality, time, and cost in relation to bringing a drug onto the market, BirdoTech can tailor process development strategies, regardless of whether a project is in the preclinical stage or is ready for commercialization. BirdoTech provides consistent supplies of bulk API in commercial quantities. Their QC team develops all the necessary protocols for technology transfer and manufacturing. Then their QA team track and document the batch-to-batch consistency for product release. They understand that their facility can be and do get audited by government agencies and sponsors regularly. Therefore, they are committed to maintaining the highest standards of regulatory and environmental compliance. Their facilities are designed to safely handle complex, multi-step organic synthesis in kilograms to multiple metric ton quantities.

BirdoTech is a well-funded organization with R&D sites in three locations. This provides a breadth of expertise in different areas of research. Recent areas of additions have included photoredox chemistry, flow chemistry toward screening and manufacturing, and peptide chemistry. They also recognized the importance of investing in people. Team members excel at their trained skill sets; they must also be invested in their client’s success. The culture at BirdoTech is—constantly be learning—and oftentimes, learning comes from their client interactions. The company understands the urgency to move quickly and advance clinical assets to commercial manufacturing. BirdoTech is helping build a healthier future for all and is poised to become a preeminent CDMO.